SCHEMBL20536616

SCHEMBL20536616

CCCCCCC1=CC=CCC1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 3/20 0.33
ESR1 P03372 2/20 0.33
ADRA2A P08913 2/20 0.33
ADORA3 P0DMS8 2/20 0.33
TACR2 P21452 2/20 0.33
SLC6A2 P23975 2/20 0.33
SLC6A4 P31645 2/20 0.33
SLC6A3 Q01959 2/20 0.33
KCNH2 Q12809 2/20 0.33
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
LMNA P02545 1/20 0.33
SHBG P04278 1/20 0.33
TP53 P04637 1/20 0.33
CYP3A4 P08684 1/20 0.33
HSPD1 P10809 1/20 0.33
ADRB3 P13945 1/20 0.33
HTR2C P28335 1/20 0.33
HSPE1 P61604 1/20 0.33
HIF1A Q16665 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18802263 1.00 PTGS2 (0.33) PTGS2ESR1ADRA2AADORA3TACR2
SCHEMBL14943805 0.98 PTGS2 (0.31) PTGS2ESR1ADRA2AADORA3TACR2
SCHEMBL9837943 0.92
SCHEMBL3038121 0.84
SCHEMBL19352858 0.83 SIGMAR1 (0.42) ALDH1A1LMNAS1PR4S1PR1S1PR3
SCHEMBL2589165 0.82 PTGS2 (0.36) PTGS2ESR1ADRA2AADORA3TACR2
SCHEMBL1539757 0.82 PTGS2 (0.36) PTGS2ESR1ADRA2AADORA3TACR2
SCHEMBL2589979 0.82 PTGS2 (0.36) PTGS2ESR1ADRA2AADORA3TACR2
SCHEMBL2581422 0.82 PTGS2 (0.36) PTGS2ESR1ADRA2AADORA3TACR2
SCHEMBL2589096 0.82 PTGS2 (0.36) PTGS2ESR1ADRA2AADORA3TACR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3392259-B1 SUBSTITUTED CYCLOPENTADIENYL COBALT COMPLEX AND METHOD FOR PRODUCTION THEREOF TOSOH CORP (JP) 2023-06-07 EP disclosed
CN-108473521-B Substituted cyclopentadienyl cobalt complex and its preparing method, cobalt-containing film and its preparing method 东曹株式会社 2021-03-12 CN disclosed
US-10336782-B2 Substituted cyclopentadienyl cobalt complex and method for production thereof, and cobalt-containing thin film and method for production thereof SAGAMI CHEMICAL RESEARCH INSTITUTE (JP) 2019-07-02 US disclosed
US-20180362568-A1 SUBSTITUTED CYCLOPENTADIENYL COBALT COMPLEX AND METHOD FOR PRODUCTION THEREOF, AND COBALT-CONTAINING THIN FILM AND METHOD FOR PRODUCTION THEREOF TOSOH CORPORATION (JP) 2018-12-20 US disclosed
EP-3392259-A1 SUBSTITUTED CYCLOPENTADIENYL COBALT COMPLEX AND METHOD FOR PRODUCTION THEREOF, AND COBALT-CONTAINING THIN FILM AND METHOD FOR PRODUCTION THEREOF Tosoh Corporation (JP) 2018-10-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10336782-B2 Substituted cyclopentadienyl cobalt complex and method for production thereof, and cobalt-containing thin film and method for production thereof SCO2, CBR3, CBR1 PTGS2 1092/4885ESR1 3440/4885ADRA2A 3843/4885
US-20180362568-A1 SUBSTITUTED CYCLOPENTADIENYL COBALT COMPLEX AND METHOD FOR PRODUCTION THEREOF, AND COBALT-CONTAINING THIN FILM AND METHOD FOR PRODUCTION THEREOF SCO2, CBR3, CBR1 PTGS2 1092/4885ESR1 3440/4885ADRA2A 3843/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.